Page last updated: 2024-09-03

op 2507 and Arteriosclerosis

op 2507 has been researched along with Arteriosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arima, T; Hirano, T; Kawano, R; Motoyama, K; Nakafusa, Y; Sugitani, A; Tanaka, M1

Other Studies

1 other study(ies) available for op 2507 and Arteriosclerosis

ArticleYear
The combined use of prostaglandin I2 analogue (OP-2507) and thromboxane A2 synthetase inhibitor (OKY-046) strongly inhibits atherosclerosis of aortic allografts in rats.
    Surgery, 2001, Volume: 129, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteriosclerosis; Cell Nucleus; Drug Therapy, Combination; Enzyme Inhibitors; Epoprostenol; Kinetics; Male; Methacrylates; Rats; Rats, Inbred Lew; Rats, Wistar; Superoxides; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Homologous

2001